BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4997642)

  • 1. [Interaction of the polyenic antibiotics levorin and amphotericin B with cholesterol].
    Klimov AN; Nikiforova AA; Etingov ED
    Antibiotiki; 1971 Mar; 16(3):243-7. PubMed ID: 4997642
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of levorin and amphotericin B on the prostate glands of white rats and on their serum cholesterol concentrations].
    Mikhaĭlets GA; Ivanov NM; Slonitskaia NN
    Antibiotiki; 1972 Sep; 17(9):802-6. PubMed ID: 4653540
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gamma-sterilization of polyenic antibiotics].
    Tsyganov VA; Vasil'eva NG
    Antibiotiki; 1971 Jan; 16(1):47-9. PubMed ID: 5553276
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative in vitro studies on liposomal formulations of amphotericin B and its derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME).
    Cybulska B; Kupczyk K; Szlinder-Richert J; Borowski E
    Acta Biochim Pol; 2002; 49(1):67-75. PubMed ID: 12136958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Partial hydrogenation of tetraen antibiotics on palladium catalyst].
    Bol'shakova LO; Belen'kii BG; Solov'ev SN
    Antibiotiki; 1966 Oct; 11(10):892-8. PubMed ID: 4968575
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid-covered drug particles: combined action of dioctadecyldimethylammonium bromide and amphotericin B or miconazole.
    Lincopan N; Carmona-Ribeiro AM
    J Antimicrob Chemother; 2006 Jul; 58(1):66-75. PubMed ID: 16636081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-amebic effect of polyenic antibiotics].
    Liubimova LK; Ovnanian KO; Ivanova LN
    Antibiot Med Biotekhnol; 1985 Mar; 30(3):179-82. PubMed ID: 2861787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of amphotericin B and sodium desoxycholate levorin on the functional state of the kidneys in dogs].
    Moiseeva MV
    Antibiotiki; 1970 Sep; 15(9):810-4. PubMed ID: 5489726
    [No Abstract]   [Full Text] [Related]  

  • 9. Antifungal drug combinations for Cryptococcus neoformans and Prototheca spp.
    Srimuang S; Prariyachatigul C; Chaiprasert A; Rungsipanuratn W; Tanphaichitra D
    J Med Assoc Thai; 2000 Jan; 83(1):57-60. PubMed ID: 10710870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate.
    Groeschke J; Solassol I; Bressolle F; Pinguet F
    J Pharm Biomed Anal; 2006 Sep; 42(3):362-6. PubMed ID: 16740372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reformulation of amphotericin B for oral administration to treat systemic fungal infections and visceral leishmaniasis.
    Thornton SJ; Wasan KM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):271-84. PubMed ID: 19327044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of nystatin and levorin on the biosynthesis of sterols and fatty acids in cell-free extracts of Saccharomyces cerevisiae].
    Klimov AN; Nikiforova AA
    Antibiotiki; 1971 Mar; 16(3):279-82. PubMed ID: 4997644
    [No Abstract]   [Full Text] [Related]  

  • 13. N-Methyl-N-D-fructosyl amphotericin B methyl ester (MF-AME), a novel antifungal agent of low toxicity: monomer/micelle control over selective toxicity.
    Cybulska B; Gadomska I; Mazerski J; Borowski JGE ; Cheron M; Bolard J
    Acta Biochim Pol; 2000; 47(1):121-31. PubMed ID: 10961685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in pharmacokinetics of amphotericin B lipid formulations despite clinical equivalence.
    Bellmann R; Egger P; Wiedermann CJ
    Clin Infect Dis; 2003 Jun; 36(11):1500-1. PubMed ID: 12766850
    [No Abstract]   [Full Text] [Related]  

  • 15. [Induction of oogenesis by polyene antibiotics and interaction with cholesterol in a Pythium sp. PRL 2142].
    Défago G; Child JJ; Haskins RH
    Can J Microbiol; 1969 Jun; 15(6):5014. PubMed ID: 5798508
    [No Abstract]   [Full Text] [Related]  

  • 16. The solubility ceiling: a rationale for continuous infusion amphotericin B therapy?
    Lewis RE; Wiederhold NP
    Clin Infect Dis; 2003 Sep; 37(6):871-2. PubMed ID: 12955666
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
    Tay ST; Tanty Haryanty T; Ng KP; Rohani MY; Hamimah H
    Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elution and mechanical properties of antifungal bone cement.
    Goss B; Lutton C; Weinrauch P; Jabur M; Gillett G; Crawford R
    J Arthroplasty; 2007 Sep; 22(6):902-8. PubMed ID: 17826283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amphotericin B on sodium and water movement across normal and cholera toxin-challenged canine jejunum.
    Chen LC; Guerrant RL; Rohde JE; Casper AG
    Gastroenterology; 1973 Aug; 65(2):252-8. PubMed ID: 4720028
    [No Abstract]   [Full Text] [Related]  

  • 20. What is the current and future status of conventional amphotericin B?
    Kleinberg M
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.